PurHealthRX ® Announces Completion of the First Major Non-pharmaceutical CBD Study in Humans

LAS VEGAS, Oct. 3, 2019 /PRNewswire/ -- PurHealthRX (®) announced the completion of the first major clinical study looking at the anti-aging effects and safety of full spectrum hemp CBD oil in human subjects. The study was completed with support from the National Institute of Health (NIH).

https://mma.prnewswire.com/media/1005439/PurhealthRX_Logo.jpg [https://mma.prnewswire.com/media/1005439/PurhealthRX_Logo.jpg ]

The randomized placebo-controlled study on 150 patients showed that full spectrum hemp CBD oil had a significant effect on a multitude of anti-aging related factors.

The study looked at inflammation markers, cardiovascular and metabolism indicators while also tracking anxiety and sleep.

"We are very pleased that our Purzorb(®) formulation of full spectrum hemp CBD oil showed such a strong effect in these anti-aging factors," said Matt Smith, CEO.

"Inflammation and cardiovascular problems are part of the aging process. By showing a significant effect on so many of these factors, there is strong evidence that the endocannabinoid system plays a significant role in the anti-aging process," Smith said.

According to Smith, this is the first non-pharmaceutical study demonstrating both the safety and efficacy of naturally occurring cannabinoids such as CBD.

PurHealthRX (®) scientists have been working on methods to deliver naturally occurring cannabinoids since 2014. "Working with industrial hemp since the 2014 Farm Bill passed has given us a great understanding of the problems that face this market," Smith explained.

"The inconsistencies, impurities and no standardization, coupled with a lack of clinical data, has created a lot of confusion with consumers who could really benefit from CBD products," Smith said. The study looked at inflammatory markers such as Tumor Necrosis Factor Alpha, Interleukin 6, C-Reactive Protein and NF- B. Metabolism and cardiovascular indicators such as HA1c, LDL/HDL and Homocysteine levels were also measured. One of the significant findings was that the HA1c levels dropped by an average of almost one point in the test subjects.

About PurHealthRX (®)

PurHealthRX (®) is a technology-driven health and wellness company that manufactures, distributes and sells full spectrum hemp CBD oil products using Purzorb(®), a proprietary technology that mimics the body's natural process of absorption by converting oil-based nutrients into water-soluble products. Purzorb(®) products are sold under the Med 7(®) and Pur 7(®) brands, and marketed as Biosorb(TM) in products sold through Q Sciences.

Logo - https://mma.prnewswire.com/media/1005439/PurhealthRX_Logo.jpg [https://c212.net/c/link/?t=0&l=en&o=2599842-1&h=427274288&u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1005439%2FPurhealthRX_Logo.jpg&a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1005439%2FPurhealthRX_Logo.jpg]

CONTACT: PurHealthRX , LLC, 601 E. Charleston Blvd Suite 100, Las Vegas, NV 89104, 877-259-6887, purhealthrx.com

Web site: http://www.purhealthrx.com/

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234